Beijing Tide Pharmaceutical Co., Ltd

This study is testing a new drug called TCC1727 in combination with other cancer medications for people with advanced solid tumors that have stopped responding to standard treatments. The first part of the study will find the safest and most effective dose. The second part will t…

This is an early safety study for a new inhaled medication called CPD704. It will test single and repeated doses in 90 healthy Chinese adults to see how safe it is and how the body processes it. The main goal is to check for side effects and measure drug levels in the blood.